НовостиBenzingaCrescent Biopharma Receives FDA Clearance For Its Investigational New Drug Application For CR-002 To Treat Advanced Solid Tumors Crescent Biopharma Receives FDA Clearance For Its Investigational New Drug Application For CR-002 To Treat Advanced Solid Tumors Benzinga 2026.10.05 11:31 (GMT+0) Открыть на Benzinga Другие новости